An In-House Perspective on Biologics/Biosimilars Litigation
Join our discussion about biologics litigation from the unique perspective of in-house counsel. The distinguished panel will discuss a variety of topics, focusing on the practical considerations and challenges that in-house counsel face when advising their internal clients about biosimilar disputes.
Kristan Lansbery, Ph.D., Senior Director, Assistant General Counsel, Patents, Regeneron Pharmaceuticals, Inc.
Tara Rahemba, Senior Director, Patent Counsel, Alexion
Karen Stoffan, Director, IP Litigation, Merck
Lori Wolfe, Associate General Counsel, North America IP Litigation, Teva Pharmaceuticals
Moderator: Hassen Sayeed, M.D., O'Melveny & Myers LLP
Hosted by the NYIPLA Patent Litigation and Women in IP committees
NYIPLA reaches a diverse community of intellectual property professionals through a wide range of programs and activities that can provide a rewarding sponsorship experience. Benefits include: sponsor recognition, logo displays, promotional materials, and more. Click HERE for Sponsorship details.